Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin

Molecular Biology of the Cell
Cary D AustinRichard H Scheller

Abstract

ErbB2 is a transmembrane tyrosine kinase whose surface overexpression is linked to tumorigenesis and poor prognosis in breast cancer patients. Two models have emerged that account for the high surface distribution of ErbB2. In one model, the surface pool is dynamic and governed by a balance between endocytosis and recycling, whereas in the other it is retained, static, and excluded from endocytosis. These models have contrasting implications for how ErbB2 exerts its biological function and how cancer therapies might down-regulate surface ErbB2, such as the antibody trastuzumab (Herceptin) or the Hsp90 inhibitor geldanamycin. Little is known, however, about how these treatments affect ErbB2 endocytic trafficking. To investigate this issue, we examined breast carcinoma cells by immunofluorescence and quantitative immunoelectron microscopy and developed imaging and trafficking kinetics assays using cell surface fluorescence quenching. Surprisingly, trastuzumab does not influence ErbB2 distribution but instead recycles passively with internalized ErbB2. By contrast, geldanamycin down-regulates surface ErbB2 through improved degradative sorting in endosomes exclusively rather than through increased endocytosis. These results reveal ...Continue Reading

References

Jul 10, 1987·Science·P P Di FioreS A Aaronson
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·E HurwitzY Yarden
Nov 1, 1993·Clinical & Experimental Metastasis·C R De Potter, J Quatacker
Jan 1, 1993·Breast Cancer Research and Treatment·C C BenzC K Osborne
Mar 1, 1996·The Journal of Biological Chemistry·J BaulidaG Carpenter
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Jun 22, 2000·The Journal of Biological Chemistry·O Tikhomirov, G Carpenter
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Jun 28, 2001·Oncogene·J Mendelsohn, J Baselga
Aug 28, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Baselga, J Albanell
Apr 16, 2002·Molecular Biology of the Cell·Martin SachseJudith Klumperman
Apr 5, 2003·Cancer Cell·Jennifer S IsaacsLen Neckers
Jan 27, 2004·Molecular Biology of the Cell·Anette M HommelgaardBo van Deurs
Mar 26, 2004·Nature Reviews. Molecular Cell Biology·Frederick R Maxfield, Timothy E McGraw
Apr 13, 2004·Molecular Biology of the Cell·Florencia B SchapiroFrederick R Maxfield
Apr 20, 2004·Cancer Cell·Matthew C FranklinMark X Sliwkowski

❮ Previous
Next ❯

Citations

Apr 15, 2008·Cancer Immunology, Immunotherapy : CII·Michael M SchmidtK Dane Wittrup
Feb 22, 2008·Histochemistry and Cell Biology·Kirstine RoepstorffBo van Deurs
Sep 1, 2005·Investigational New Drugs·Christina H Yeon, Mark D Pegram
Sep 2, 2006·Journal of Mammary Gland Biology and Neoplasia·Ali Badache, Anthony Gonçalves
Dec 29, 2012·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Yu ZhangQiang Fu
Jan 20, 2010·Cell Stress & Chaperones·Candice S Gerbin, Ralf Landgraf
Jul 13, 2013·Biologicals : Journal of the International Association of Biological Standardization·Hoda AyatMehdi Arbabi
Aug 11, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Fernando PastorEli Gilboa
Sep 10, 2005·Nature Biotechnology·Gregory P Adams, Louis M Weiner
Jul 26, 2008·Nature Nanotechnology·Wen JiangWarren C W Chan
Jun 19, 2009·Nature Reviews. Cancer·José Baselga, Sandra M Swain
Dec 8, 2010·Nature Reviews. Clinical Oncology·Alberto OcanaIan F Tannock
Apr 20, 2006·Nature Reviews. Immunology·Paul J Carter
May 5, 2009·Cancer Biotherapy & Radiopharmaceuticals·Stephen I Rudnick, Gregory P Adams
May 12, 2006·Molecular Biology of the Cell·Christine Y Chen, William E Balch
Jul 13, 2007·Molecular Biology of the Cell·Mads LerdrupBo van Deurs
Jul 19, 2012·Biochemistry. Biokhimii︠a︡·O L PolanovskiS M Deyev
Apr 22, 2010·Cancer Research·Corina MarxChristopher C Benz
Dec 24, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Smitha ReddyMatthew K Robinson
Nov 26, 2010·BMC Biotechnology·Rainer LoewManfred Gossen
Sep 4, 2008·Journal of Cell Science·Daniel J BarrDeborah A Brown
May 14, 2009·PloS One·Han LiuSylvie Urbé
Jun 3, 2014·Breast Cancer Research : BCR·Mark BarokJorma Isola
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jamie B SpanglerK Dane Wittrup
Jun 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Cary D AustinAvi Ashkenazi
Dec 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Cary D AustinSuzie J Scales

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.